Cargando…
Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature
In patients with hepatocellular carcinoma characterized by vascular invasion and/or extrahepatic disease, Sorafenib is considered treatment of choice. Although mild liver test abnormalities were reported in less than 1% of the patients in the two large randomized, controlled phase III trials, four c...
Autores principales: | Van Hootegem, Anneleen, Verslype, Chris, Van Steenbergen, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411881/ https://www.ncbi.nlm.nih.gov/pubmed/25954549 http://dx.doi.org/10.1155/2011/941395 |
Ejemplares similares
-
Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy
por: Kuroda, Daisuke, et al.
Publicado: (2016) -
Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature
por: Lin, Yun, et al.
Publicado: (2013) -
Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature
por: Wu, Dong-Bo, et al.
Publicado: (2017) -
Sorafenib in metastatic MTC – a case report and minireview of the literature
por: Petrova, Mila, et al.
Publicado: (2010) -
Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review
por: Pan, Dan, et al.
Publicado: (2022)